Showing posts with label future prospects. Show all posts
Showing posts with label future prospects. Show all posts

Friday, 26 April 2024

A Comprehensive Analysis of the Medicinal Use of Bioactive Secondary Metabolites from the Genus Ehretia | Chapter 8 | Recent Developments in Chemistry and Biochemistry Research Vol. 2

The roughly 150 species of plants that make up the genus Ehretia are primarily found in tropical regions of North America, Africa, Australia, and Asia. They have long been used as traditional and folk remedies in China, India, and Japan to cure a wide range of illnesses. Pharmacological investigations verified that the genus's crude extracts or specific components had anti-snake venom properties in addition to antioxidant, anti-inflammatory, antibacterial, anti-arthritic, anti- tubercular, and anti-allergic properties. Based on the available literature up to February 2024, summery of secondary metabolites that have been identified from several species of Ehretia in this literature. Chapter concentrated on the known biological activities of the Ehretia plants and covered them in detail here, in addition to their traditional therapeutic usage.


Author(s) Details:

Amanpreet Kaur,
Department of Chemistry, School of Sciences, IFTM University, Moradabad-244102, Uttar Pradesh, India.

Abha Shukla,
Department of Chemistry, Kanya Gurukula Campus, Gurukula Kangri Vishwavidyalaya, Haridwar-249404, Uttarakhand, India.

Sarika Arora,
Department of Chemistry, School of Sciences, IFTM University, Moradabad-244102, Uttar Pradesh, India.

Trapti Pandey,
Department of Home Sciences, School of Sciences, IFTM University, Moradabad-244102, Uttar Pradesh, India.

Priyanka Pokhriyal,
Department of Chemistry, Kanya Gurukula Campus, Gurukula Kangri Vishwavidyalaya, Haridwar-249404, Uttarakhand, India.

Please see the link here: https://stm.bookpi.org/RDCBR-V2/article/view/14254

Sunday, 6 June 2021

A Case Study on Pompe Disease: Presentation and Management of Early Onset Type with Perioperative Considerations | Chapter 1 | Challenges in Disease and Health Research Vol. 8

 Early onset of the disease Pomp disease is an uncommon condition that is frequently misdiagnosed. It is characterised by hypotonia, muscular weakness, and cardiopulmonary failure. The GAA enzyme is a sensitive and specific disease marker that may be measured in the blood. Early intervention with enzyme replacement therapy (ERT) reduces morbidity and improves long-term survival, but it is both costly and lifelong. On the horizon, gene therapy appears to be promising.


Author (s) Details

Raeesa Bulbulia
Garden City Clinic, Johannesburg, South Africa.

B. A. Bulbulia
Garden City Clinic, Johannesburg, South Africa.

Nazeefah Laher
Garden City Clinic, Johannesburg, South Africa.

View Book :- https://stm.bookpi.org/CDHR-V8/article/view/1419